Shuttle Pharmaceuticals Holdings (SHPH) Interest & Investment Income (2023 - 2026)

Shuttle Pharmaceuticals Holdings has reported Interest & Investment Income for 4 years, with the latest figure at $209.0 in Q1 2026.

• On a quarterly basis, Interest & Investment Income changed N/A year-over-year to $209.0 in Q1 2026; TTM through Mar 2026 was $1299.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1090.0, down 97.14% from the prior year.
• Interest & Investment Income was $209.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from $523.0 in the prior quarter.
• The five-year high for Interest & Investment Income was $22397.0 in Q4 2023, with the low at $3.0 in Q4 2024.
• Average Interest & Investment Income over 4 years is $9879.5, with a median of $8341.0 recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Interest & Investment Income plunged 99.99% in 2024, then surged 17333.33% in 2025.
• Over 4 years, Interest & Investment Income stood at $22397.0 in 2023, then slumped by 99.99% to $3.0 in 2024, then soared by 17333.33% to $523.0 in 2025, then slumped by 60.04% to $209.0 in 2026.
• The last three Interest & Investment Income figures came in at $209.0 (Q1 2026), $523.0 (Q4 2025), and $486.0 (Q3 2025), per Business Quant data.